Transplantation of solid organs during the pandemic of a new coronavirus infection

• Published in: Transplantologii͡a Vol. 15; no. 3; pp. 376 - 389
• Main Authors: Shumakov, D. V., Zybin, D. I., Zulkarnaev, A. B., Dontsov, V. V., Agafonov, E. G., Popov, M. A.
• Format: Journal Article
• Language: English
• Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 14-09-2023
• Subjects: heart transplantation; kidney transplantation; liver transplantation; new coronavirus infection; viral infection
• ISSN: 2074-0506; 2542-0909
• DOI: 10.23873/2074-0506-2023-15-3-376-389

The end-stage stage of chronic diseases of solid organs is rather significant in the structure of morbidity and mortality among patients worldwide. To date, there are more than six million patients in this status worldwide. Heart, liver and kidney transplantation is the gold standard of treatment for these patients. The number of transplants is growing every year.At the end of 2019, the world faced a new type of viral infection – SARS-CoV-2 – a highly contagious systemic respiratory disease transmitted by airborne droplets, which in three months led to a pandemic and killed hundreds of thousands of people. The pandemic has made adjustments to the structure of planned medical care. The number of planned operations has decreased significantly, and the number of the infection-associated complications has increased.Patients with end-stage chronic diseases initially have weakened immunity and represent the category most susceptible to the infection. At the moment, the question of patient management tactics remains open. There is no consensus on the patient management tactics before surgery and in the posttransplantation period for patients at the end-stage chronic disease of different organs. This topic requires further study and the development of treatment algorithms for such patients.